The Catholic University of America

Child Cognition, Affect, and Behavior Laboratory  (C.A.B. Lab)



Lab Director: Brendan A. Rich, Ph.D.

Research Team: Graduate and Undergraduate Students


Conference Presentations

Prospective Students





Recent Lab News

  • Congratulations to Serene Habayeb, 4th year Clinical PhD student.  She has been awarded two grants to fund her dissertation "Stress, Coping, Stigma, and Acculturation in Arab American Caregivers of Children with Autism and other Developmental Disabilities": 1) the Society for Research in Child Development (SRCD) Dissertation Funding Award, and; 2) the Dr. Philip M. Kayal Fund for Arab American Research Dissertation Award. 
  • Congratulations to Dr. Heather Rosen, who successfully defended her dissertation "Examining the Effectiveness of a Resilience-Based Group Intervention for the Treatment of Youth with Mood and Behavior Dysregulation".  Heather is completing her post-doctoral Fellowship at the Stanford University Outpatient Child and Adolescent Psychiatry Clinic.
  • Congratulations to Dr. Candice Watson, who successfully defended her dissertation "Influence of Parental Collaboration on Group Therapy Outcomes for Anxious Children". Candice is completing her post-doctoral Fellowship at the Behavior Therapy Center of Greater Washington.
  • Congratulations to Meagan Wills, who is completing her pre-doctoral Internship at the Yale University Child Study Center.
  • Our research collaboration with Dr. Mary Alvord and the Alvord, Baker & Associates private practice is discussed in a recent press release by Research Press Publishers.


Research Programs

The CAB Lab is dedicated to understanding the cognitive, affective, and behavioral deficits associated with childhood psychopathology, in particular mood disorders.

The primary focus of the Lab's work is to determine the effectiveness of a group therapy program for children with deficits in social skills and self-regulation. In collaboration with Mary Alvord, PhD, this project investigates the effectiveness of the Resilience Builder Program (RBP), a manualized resilience-based group therapy program for children in a clinical service setting. Most of these youth have diagnosed anxiety disorders, attention deficit hyperactivity disorder (ADHD), or Autism Spectrum Disorders (ASD). This study explores the effectiveness of this group therapy based on parent, teacher, and child report using measures of internalizing and externalizing symptomatology, emotional arousal and control, and family functioning. In addition, therapeutic outcome is assessed using structured diagnostic interviews as well as objective affective and behavioral indices of self-regulation via a computer task. 

We are extending the Resilience Builder Program to schools in Washington, DC and Maryland.  There, we are administering RBP to youth who are primarily ethnic minorities and from disadvantaged communities in an effort to determine the effectiveness of RBP in the school setting.

Finally, we are also collaborating with researchers at the National Human Genome Research Institute (NHGRI) at NIH to examine potential genetic and neurophysiological predictors of response to the Resilience Builder Program, as well as changes in neurological functioning following the RBP therapy.